NOVEMBER 2015 – Four trial dates are set for early 2017 for the consolidated multidistrict litigation (MDL) against Bayer AG and a Johnson and Johnson subsidiary regarding injuries sustained by Xarelto patients. U.S. District Judge Eldon Fallon in the Eastern District of Louisiana issued the order for trial dates of February 6, 2017 and March

 Matthew McCarley, a partner at Fears | Nachawati Law Firm, has been appointed to the Plaintiffs’ Executive Committee (PEC) in the multidistrict litigation (MDL) regarding Inferior Vena Cava (IVC) Filters manufactured by Cook Group, Inc.   IVC Filters were implanted to prevent blood clots from becoming coronary or pulmonary embolisms. However, reports first surfaced in

Xarelto, the blockbuster anticoagulant that was approved by the FDA in 2011, has continued to come under scrutiny by parts of the medical community. Initially, the drug was approved to help reduce the risk of blood clots in patients who had undergone knee or hip replacement. Later, Xarelto was approved to help patients with deep

Another transvaginal mesh manufacturer has agreed to settle with injured plaintiffs. This time, the company is Covidien, which has agree to settle some of the 11,000 claims that are currently being made against them. Covidien has supplied C.R. Bard with mesh products, specifically Bard’s Avaulta pelvic mesh. In 2013, Bard was ordered to pay Donna

Judge Joseph Goodwin, the federal judge in charge of overseeing multidistrict litigation involving transvaginal mesh and sling products, has moved to consolidate more than a dozen such lawsuits for jury trial this November. The decision came on June 12th, when he consolidated 26 transvaginal mesh lawsuits into a single trial which is set to begin